Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists

BACKGROUND: In multiple sclerosis (MS), bridging therapies are usually administered when switching from one therapy to another. Such treatments generally consist of injectable immunomodulatory drugs (interferon or glatiramer acetate), whose efficacy, safety, and tolerability data are consolidated fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Marfia, Girolama Alessandra, Centonze, Diego, Salvetti, Marco, Ferraro, Elisabetta, Panetta, Valentina, Gasperini, Claudio, Mirabella, Massimiliano, Conte, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337240/
https://www.ncbi.nlm.nih.gov/pubmed/35911920
http://dx.doi.org/10.3389/fneur.2022.898741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337240/
https://www.ncbi.nlm.nih.gov/pubmed/35911920
http://dx.doi.org/10.3389/fneur.2022.898741

Ejemplares similares